跳至主要内容
临床试验/JPRN-UMIN000020663
JPRN-UMIN000020663已完成未知

A clinical study to evaluate the correlation between the efficacy and the immunological markers in patients with rheumatoid arthritis treated with Tofacitinib. - A clinical study to evaluate the correlation between the efficacy and the immunological markers in patients with rheumatoid arthritis treated with Tofacitinib.

Kyusyu University Hospital Medicine and biosystemic science0 个研究点目标入组 20 人开始时间: 2016年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.A patient with tuberculosis or non-tuberculous mycobacteria. 2 .A patient who is positive for HBs antigen or HBV DNA not receiving nucleotide analogue. 3. A patient who has an active infectious disease. 4. A patient who has concurrent malignancy or its previous history. 5. A patient with reduced renal function less than CLcr15/min. 6. A patient with reduced hepatic function more than 10 points of Child-Pugh score (grade C) 7. A patient with interstitial pneumonia. 8. A pregnant or breastfeeding women or a women who may be pregnant. 9. A patient who has hypersensitivity reaction to ingredients in this drug. 10. A patient who meets any of followings: less than 1000/mm3 peripheral neutrophils or less than 8g/dL hemoglobin. 11. A patient who is regarded as inappropriate to participate in the study by a doctor.

研究者

发起方
Kyusyu University Hospital Medicine and biosystemic science

相似试验